FROM Paul Howard
Does Obamacare have a future after all? For six years, Republicans in Congress have voted to repeal and replace the Affordable Care Act, long dubbed "Obamacare." Now, with majorities in both Houses and Donald Trump in the White House, the process is beginning today. But in both houses, the GOP is divided. One side worries that supporters of President Trump may be among the millions who lose health insurance. The other says the new plan doesn't go far enough and complain its toughest provisions won’t take effect until 2020. They call it "Obamacare Light." Nobody knows the possible cost yet — and, as we hear, politics will be more important than substance.
America's Wild West of Drug Pricing Earlier this year, when pharma exec Martin Shkreli bought the rights to an old drug and then raised its price 5000%, Americans named him the most hated man in the country. But he is only doing what Big Pharma does everyday thanks to patent laws and America's free market approach to drug pricing. Rising costs are outraging patients, doctors and health insurers all along the political spectrum, but with all the money Big Pharma spends on lobbying, will Washington take up drug pricing reform?
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.